Drug Trial Radar · NCT05514106
MIBG in Aging and Neurologic Disorders
Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
50
Planned (sponsor's estimate)
Start
May 8, 2023
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to investigate the use of a special radioactive drug called 123I-MIBG and myocardial MIBG scintigraphy. This scan may be able to help determine who may have a certain kind of neurologic disorder called Lewy Body Disease. The overall purpose of this study is to correlate myocardial MIBG scintigraphy findings with clinical diagnosis. Myocardial MIBG scintigraphy imaging will be combined with other clinical, neuropsychological and neuroimaging findings to improve the prediction for underlying Lewy Body Disease.
Conditions
- Lewy Body Disease
- Dementia
- Parkinsonism
- Mild Cognitive Impairment
- REM Sleep Behavior Disorder
Interventions
meta-iodobenzylguanidine (MIBG) (123I)Drug
1 administration of 123I-MIBG for a single SPECT scan
123I-MIBG scintigraphyDiagnostic test
SPECT scan involving 123I-MIBG as the ligand
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correlate myocardial 123I-MIBG scintigraphy findingsTime frame: 10 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic in Rochester
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.